share_log

Biohaven Reports Pricing Of Public Offering Of 5.609M Of Its Common Shares At $41 Per Share

Biohaven Reports Pricing Of Public Offering Of 5.609M Of Its Common Shares At $41 Per Share

Biohaven報告稱，其560.9萬股普通股的公開發行定價爲每股41美元
Benzinga ·  04/18 18:02

The gross proceeds from the offering are expected to be approximately $230 million before deducting underwriting discounts and commissions and offering expenses payable by Biohaven. Biohaven intends to use the net proceeds received from the offering for general corporate purposes.

在扣除承保折扣和佣金以及Biohaven應付的發行費用之前，此次發行的總收益預計約爲2.3億美元。Biohaven打算將此次發行的淨收益用於一般公司用途。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論